Inhaled Corticosteroids and the Risk of Pneumonia in People With Asthma
about
Pharmacotherapy in the management of asthma in the elderly: a review of clinical studiesUse of ICS/LABA (extra-fine and non-extra-fine) in elderly asthmaticsGuidelines for diagnosis and management of bronchial asthma: Joint ICS/NCCP (I) recommendationsUtilization of inhaled corticosteroids for infants with bronchopulmonary dysplasiaCommon Infections in Patients Prescribed Systemic Glucocorticoids in Primary Care: A Population-Based Cohort StudyChallenges in the pharmacological treatment of geriatric asthma.Infection in severe asthma exacerbations and critical asthma syndrome.Risk of pneumonia in obstructive lung disease: A real-life study comparing extra-fine and fine-particle inhaled corticosteroids.Respiratory review of 2014: asthmaInfluence of lung function on course of disease and response to antibiotic therapy in adult primary care patients with acute cough: a post hoc analysis of patients enrolled in a prospective multicentre study.Glucocorticoid-Augmented Efferocytosis Inhibits Pulmonary Pneumococcal Clearance in Mice by Reducing Alveolar Macrophage Bactericidal Function.Choosing wisely: practical considerations on treatment efficacy and safety of asthma in the elderly.Retrospective cohort evaluation on risk of pneumonia in patients with pulmonary tuberculosis.Post-Inhaled Corticosteroid Pulmonary Tuberculosis Increases Lung Cancer in Patients with Asthma.The risk and outcomes of pneumonia in patients on inhaled corticosteroids.Corticotropin-releasing hormone improves survival in pneumococcal pneumonia by reducing pulmonary inflammation.Asthma-Related Outcomes in Patients Initiating Extrafine Ciclesonide or Fine-Particle Inhaled Corticosteroids.Glucocorticosteroids enhance replication of respiratory viruses: effect of adjuvant interferon.Meta-review: adverse effects of inhaled corticosteroids relevant to older patients.The acute management of asthma.A review of standard pharmacological therapy for adult asthma – Steps 1 to 5.Emerging corticosteroid agonists for the treatment of asthma.Inhaled Glucocorticoids and Pneumonia in Preterm Infants: Post Hoc Results from the NEuroSIS Trial.Successful treatment of pulmonary nocardiosis with fluoroquinolone in bronchial asthma and bronchiectasis.Pneumonia risk in asthma patients using inhaled corticosteroids: a quasi-cohort study.Human Metapneumovirus Infection in Chronic Obstructive Pulmonary Disease: Impact of Glucocorticosteroids and Interferon.TAK1 inhibition attenuates both inflammation and fibrosis in experimental pneumoconiosis.Asthma referrals: a key component of asthma management that needs to be addressed.Pneumococcal vaccination among adults with work-related asthmaEotaxin-3 (CCL26) exerts innate host defense activities that are modulated by mast cell proteases.Prevalence and management of severe asthma in primary care: an observational cohort study in Sweden (PACEHR).Tracheobronchopathy From Inhaled Corticosteroids.Brg1 inhibits E-cadherin expression in lung epithelial cells and disrupts epithelial integrity.Design of a Clinical Decision Support System for Fracture Prediction Using Imbalanced Dataset.
P2860
Q26769046-534562FB-AA45-4672-89E0-F798CAFC619FQ28066822-2195EBD2-5108-4C1B-BE79-769D8402C1FFQ28392274-62EB303B-1A1F-4750-8533-D1CCC86A2EC0Q28542831-F1DC75B8-446C-41FF-B550-B9EFA3AC2A26Q28602277-8F81260A-2DFD-45EA-B5A2-62DE1B8A8FB5Q30251770-DC9F6C45-31A1-4A82-86D1-B20B36DA8560Q30364236-30A39145-A04E-4A91-8F1F-FF2064EF6543Q33803143-6E4582CC-84D1-4C2A-8DDF-4F836D334E6DQ34865565-54984836-12BC-49D0-8913-FCD7159DC5C8Q35216370-C1A7B986-08A7-4E1D-AA9F-F3CF7CBA3037Q35762822-B33B162F-C0AE-442B-A474-4A1C4FF6C948Q35765263-E8EDB86D-5BCB-4AC1-AD8B-BDBE5CBF5AFEQ37077952-E5BE3F85-DBA5-4F70-BB27-8D4357434D03Q37119224-A3CE23DA-8978-4671-83AF-D52CA887098BQ37364624-27BA67A9-D971-4B11-AF2F-1BDCFA6A08CCQ37599587-8A87AED1-36E9-4B9E-B26A-1F79A5A461A7Q37606269-2878F9F8-1830-4046-B35A-73508E5D9863Q37741110-EE0F4EED-D683-48DC-B2B6-BCCC0C9F76B2Q38198574-45B23357-5883-469B-9317-3FBDD154B916Q38248502-08FB1578-99F6-47B7-96F5-9E093BB8D483Q38364832-10666805-B16C-4162-B862-FC98224CA5FFQ38537176-0DFFE719-C5FB-4AF8-9946-9ED9002A1D81Q38812639-18DB9534-386C-42B6-80FC-0311A3354E23Q40063504-AFC939A0-5D08-4AD3-B4D0-CCDA6F724486Q40235200-8007FA01-AAC1-4540-9213-00914A45CC50Q40257015-68EA773C-70B3-41D5-8726-0D35AED48671Q40976804-B58D8F83-AB2A-428C-88BB-5A08E8F639F9Q41184141-5935CB7C-5CFF-43A5-B8DE-52E490352F18Q41571376-FB5B32F4-2BA4-4134-B69C-12FC37FFA7F4Q41672961-815C260B-CD59-4786-BC23-3A6B4D36FC4FQ47643706-98E57C85-2007-4048-A33C-3B562C27977AQ47785661-4D5A977E-2FD2-4AFE-A1F7-C968FB47338CQ47802348-CE01BF2E-8061-4CC9-BE41-76FD2F98D4A0Q55356076-ACAC94CF-4D5F-466D-B87D-49899F48C31C
P2860
Inhaled Corticosteroids and the Risk of Pneumonia in People With Asthma
description
im Dezember 2013 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в грудні 2013
@uk
name
Inhaled Corticosteroids and the Risk of Pneumonia in People With Asthma
@en
Inhaled Corticosteroids and the Risk of Pneumonia in People With Asthma
@nl
type
label
Inhaled Corticosteroids and the Risk of Pneumonia in People With Asthma
@en
Inhaled Corticosteroids and the Risk of Pneumonia in People With Asthma
@nl
prefLabel
Inhaled Corticosteroids and the Risk of Pneumonia in People With Asthma
@en
Inhaled Corticosteroids and the Risk of Pneumonia in People With Asthma
@nl
P356
P1433
P1476
Inhaled Corticosteroids and the Risk of Pneumonia in People With Asthma
@en
P2093
Richard Hubbard
Timothy W. Harrison
P304
P356
10.1378/CHEST.13-0871
P407
P577
2013-12-01T00:00:00Z